New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registry.

Tanaka A;Giustino G;Briede I;Sawaya FJ;Daemen J;Kawamoto H;Meliga E;D'Ascenzo F;Cerrato E;Stefanini G. G.;Capodanno D;Mangiameli A;Templin C;Erglis A;Morice MC;Mehran R;Van Mieghem NM;Nakamura S;De Benedictis M;Pavani M;Varbella F;Pisaniello M;Sharma SK;Tamburino C;Tchetche D;Colombo A;Chieffo A.

2019-01-01